Advertisement

Pharmacy

Home Pharmacy
In the United States

2018 to 2019 Influenza Season in U.S. Was Longest in 10 Years

Season was of moderate severity and lasted 21 weeks; illness mainly attributed to influenza A viruses
A substantial proportion of older patients with high-risk acute myeloid leukemia treated with chemotherapy are long-term survivors

High Response Seen for Chemo in Seniors With High-Risk AML

Complete response rate for patients treated with chemo was 69 percent; three-year OS was 21 percent
Late-life women with osteoporosis

Elderly Women May Still Benefit From Osteoporosis Treatment

High hip fracture probability seen despite accounting for competing mortality risk
Almost all health care workers with acute respiratory illness report working at least one day while symptomatic

Health Care Workers With ARIs Often Work While Symptomatic

Likelihood of working higher if symptoms less severe and on illness onset date versus subsequent days
For cardiac patients with thorax and head or neck cancer

Statins May Be Beneficial After Radiation to Thorax, Head, Neck

Statin use tied to reduction in stroke incidence for cardiac patients with thorax and head or neck cancer
For patients with relapsed multiple myeloma

Cardiovascular AEs Common With Carfilzomib in Multiple Myeloma

Patients with relapsed multiple myeloma experiencing CVAEs had inferior survival
Sudden unexpected death in epilepsy can occur across the full spectrum of epilepsies

Sudden Death Can Occur in Full Spectrum of Epilepsies

Only 37 percent of patients with sudden unexpected death in epilepsy took last dose of antiseizure meds
Patients undergoing partial knee replacement have a reduced risk for venous thromboembolism and opioid use in months 3 to 12 after surgery

VTE Risk Reduced With Partial Knee Replacement

But risk for five-year revision higher for those undergoing partial versus total knee replacement
Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older

FDA Approves Victoza Injection for Children 10 Years and Older

~64 percent of children treated with Victoza achieved HbA1c levels less than 7 percent
The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients with advanced non-small cell lung cancer

Adding Bevacizumab Improves Overall Survival in NSCLC

Addition of bevacizumab to carboplatin/pemetrexed beneficial in advanced non-small cell lung cancer